InVivo Therapeutics Holdings Corp (NVIVQ)

[treo]

PT RAISED TO $7 from $6!

Invivo Therapeutics Holdings Corp Price Target Raised to $7.00 at Aegis (NVIV)
August 23rd, 2013 •

Research analysts at Aegis raised their price objective on shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) from $6.00 to $7.00 in a report released on Friday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Aegis’ price objective would suggest a potential upside of 69.33% from the company’s current price.

Shares of Invivo Therapeutics Holdings Corp (NASDAQ:NVIV) traded down 3.73% during mid-day trading on Friday, hitting $3.98. 600,597 shares of the company’s stock traded hands. Invivo Therapeutics Holdings Corp has a 52-week low of $1.25 and a 52-week high of $6.20. The stock’s 50-day moving average is $4.64 and its 200-day moving average is $3.33. The company’s market cap is $312.7 million.